BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2056 related articles for article (PubMed ID: 8784367)

  • 21. Matched unrelated bone marrow transplantation for combined immunodeficiency.
    Dalal I; Reid B; Doyle J; Freedman M; Calderwood S; Saunders F; Roifman CM
    Bone Marrow Transplant; 2000 Mar; 25(6):613-21. PubMed ID: 10734295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of unrelated-donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study.
    Bradley BA; Hows JM; Gore SM; Bidwell JL; Clay T; Downie TR; Gluckman E; Howard MR; Laundy GJ
    Clin Transpl; 1992; ():91-107. PubMed ID: 1306726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources.
    Souillet G; Guffon N; Maire I; Pujol M; Taylor P; Sevin F; Bleyzac N; Mulier C; Durin A; Kebaili K; Galambrun C; Bertrand Y; Froissart R; Dorche C; Gebuhrer L; Garin C; Berard J; Guibaud P
    Bone Marrow Transplant; 2003 Jun; 31(12):1105-17. PubMed ID: 12796790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
    Kedar E; Or R; Naparstek E; Zeira E; Slavin S
    Bone Marrow Transplant; 1988 Mar; 3(2):129-40. PubMed ID: 3048477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.
    Ash RC; Casper JT; Chitambar CR; Hansen R; Bunin N; Truitt RL; Lawton C; Murray K; Hunter J; Baxter-Lowe LA
    N Engl J Med; 1990 Feb; 322(8):485-94. PubMed ID: 2300120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Ball E; Cook D; Andresen S; Kuczkowski E; Bolwell B
    Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft-versus-host disease following transplantation of 'one log' versus 'two log' T-lymphocyte-depleted bone marrow from HLA-identical donors.
    Löwenberg B; Wagemaker G; van Bekkum DW; Sizoo W; Sintnicolaas K; Hendriks WD; Hagenbeek A
    Bone Marrow Transplant; 1986 Dec; 1(2):133-40. PubMed ID: 3332128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
    Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas JA; Berlanga JJ; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
    Bone Marrow Transplant; 1997 Dec; 20(11):945-52. PubMed ID: 9422473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic bone marrow transplantation in children from other than HLA-identical sibling donor.
    Locatelli F; Bongiorno M; Zecca M; Giani S; Giorgiani G; Guagnini R; Morandi P; Porta F; Nespoli L; Burgio GR
    Bone Marrow Transplant; 1991; 7 Suppl 3():124-7. PubMed ID: 1855074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID).
    Dickinson AM; Reid MM; Abinun M; Peak J; Brigham K; Dunn J; Cant AJ
    Bone Marrow Transplant; 1997 Feb; 19(4):323-9. PubMed ID: 9051241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transplantation of highly purified CD34+ hematologic peripheral stem cells from haploidentical related donors in the treatment of children with non-malignant diseases].
    Starý J; Sedlácek P; Vodvárková S; Poloucková A; Formánková R; Gasová Z; Marinov I
    Cas Lek Cesk; 2002 Mar; 141(6):176-81. PubMed ID: 11977835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F; Sato K; Kobayashi S; Ikeda T; Sao H; Okamoto S; Miyamura K; Mori S; Akiyama H; Hirokawa M; Ohto H; Ashida H; Motoyoshi K;
    Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients.
    Przepiorka D; Chan KW; Champlin RE; Culbert SJ; Petropoulos D; Ippoliti C; Khouri I; Huh YO; Vreisendorp H; Deisseroth AB
    Bone Marrow Transplant; 1995 Dec; 16(6):737-41. PubMed ID: 8750262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unrelated donor marrow transplantation for inborn errors.
    Miano M; Porta F; Locatelli F; Miniero R; La Nasa G; Di Bartolomeo P; Giardini C; Messina C; Balduzzi A; Testi AM; Garbarino L; Lanino E; Crescenzi F; Zecca M; Dini G
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S37-41. PubMed ID: 9630323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 103.